definiens: within the meaning of the Private Securities Litigation Reform Actof 1995 ( PSLRA ) . These forward - looking statements involve certain risks and uncertainties . Such risks anduncertainties could cause our actual results to differ materially from those indicated by such forward - lookingstatements, and include, without limitation : the success, cost and timing of our product development activities andclinical trials and our ability to successfully advance our TCR therapeutic candidates through the regulatory andcommercialization processes . For a further description of the risks and uncertainties that could cause our actualresults to differ materially from those expressed in these forward - looking statements, as well as risks relating to ourbusiness in general, we refer you to our Quarterly Report on Form 10 - Q filed with the Securities and ExchangeCommission ( SEC ) on August 3, 2017, and our other SEC filings . The forward - looking statements contained in this press release speak only as of thedate the statements were made and we do not undertake any obligation to update such forward - looking statements toreflect subsequent events or circumstances